Novolog Mix 70/30 Injection, Suspension
Product Images NDC 70518-2119

Product Visual Gallery

This gallery contains 48 technical images submitted to the FDA as part of the official labeling for Novolog Mix 70/30 (NDC 70518-2119). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Novolog Mix 70 30 Flexpen 100 Units mL(u 100) 70518 2119 00

Label for NovoLog Mix 70/30 FlexPen insulin aspart protamine injectable suspension, 100 Units/mL (U-100) in a prefilled syringe. The package contains 5 syringes for single patient use. Label includes storage instructions, manufacturer Novo Nordisk A/S in Denmark, and repackager RemedyRepack Inc.*

FDA Label Image

Export 04

Line graph depicting mean serum insulin levels (mU/L) over 24 hours following administration of NovoLog Mix 70/30. The x-axis represents time in hours, and the y-axis shows mean serum insulin concentrations. Data points indicate means with standard error of the mean (SEM).*

FDA Label Image

Export 05

A line graph depicting the glucose infusion rate (mg/kg*min) over time (hours) for NovoLog Mix 70/30 insulin aspart injection. The graph shows a rapid increase in glucose infusion rate peaking within the first few hours, followed by a gradual decline over a 24-hour period.*

FDA Label Image

Molecular Chain Of Insulin Aspart. (Image 01)

Chemical structure diagram showing the amino acid sequence of insulin aspart, with labeled A-chain and B-chain peptides, including disulfide bonds connecting cysteine residues.*

FDA Label Image

Flexpen Components (Image 04)

An instructional diagram of the NovoLog Mix 70/30 FlexPen injection device, displaying its components from left to right: pen cap, rubber stopper, 12 glass units ball, cartridge scale, cartridge, pointer, dose selector, and push-button. The diagram visually details the parts of the subcutaneous insulin aspart injection pen by RemedyRepack Inc.*

FDA Label Image

Needle Components. (Image 05)

Illustrative diagram showing the components of three types of NovoFine needle devices: NovoFine, NovoFine Plus, and NovoTwist. Each type displays a big outer needle cap, an inner needle cap, the needle itself, and a protective tab arranged from left to right.*

FDA Label Image

Figure D: Screw Needle On. (Image 06)

An instructional illustration showing how to use the NovoFine and NovoFine Plus needles with a NovoTwist pen device. The left side depicts attaching the needle, and the right side shows preparing the pen for injection by twisting off the outer needle cap.*

FDA Label Image

Image Of Possible Injection Sites. (Image 09)

An anatomical illustration showing the front and back views of a human figure with marked areas indicating recommended subcutaneous injection sites, including the abdomen, upper arm, thigh, and buttocks.*

FDA Label Image

Important (Image 10)

FDA Label Image

Important (Image 11)

FDA Label Image

Important (Image 12)

FDA Label Image

Important (Image 13)

FDA Label Image

Important (Image 14)

FDA Label Image

Important (Image 15)

FDA Label Image

Important (Image 16)

FDA Label Image

Important (Image 17)

FDA Label Image

Important (Image 18)

FDA Label Image

Important (Image 19)

FDA Label Image

Important (Image 20)

FDA Label Image

Important (Image 21)

FDA Label Image

Important (Image 22)

FDA Label Image

Important (Image 23)

FDA Label Image

Important (Image 24)

FDA Label Image

Figure E: Pull Off Outer Needle Cap. (Image 25)

An instructional illustration showing how to attach a NovoFine or NovoFine Plus needle and a NovoTwist needle to an insulin pen device. The image demonstrates the direction to twist or push to secure the needles properly before injection.*

FDA Label Image

Figure F: Pull Off Inner Needle Cap. (Image 26)

Illustration depicting the assembly or connection process involving NovoFine and NovoTwist devices, likely used for preparing NovoLog Mix 70/30 insulin injection. The images show hands manipulating the devices, with arrows indicating the direction or steps for attachment or use.*

FDA Label Image

Vial Figure (Image 35)

An illustration showing a vial with a tamper-resistant cap and a rubber stopper located under the cap, representing the packaging features of an injectable drug vial.*

FDA Label Image

Hand & Vial Figure (Image 36)

An instructional line drawing of a hand holding a small vial or bottle, likely demonstrating proper handling or positioning for an injection suspension product such as NovoLog Mix 70/30 insulin aspart.*

FDA Label Image

Figure A & Figure B (Image 37)

An instructional illustration showing two hands holding and manipulating a vial with a screw-on cap. Figure A shows the removal of the vial cap, and Figure B shows an additional step, likely related to preparation before injection.*

FDA Label Image

Figure C (Image 38)

An instructional illustration showing a hand with the palm facing up and an arrow indicating side-to-side movement above the wrist area, possibly demonstrating a technique related to injection or medication administration.*

FDA Label Image

Figure D (Image 39)

An instructional illustration depicting a hand holding a syringe with a needle and a vial. The image includes a downward arrow indicating the action of drawing liquid from the vial into the syringe. An inset zooms in on the syringe barrel, showing it filled with liquid, emphasizing the syringe filling step.*

FDA Label Image

Figure E (Image 40)

An instructional illustration labeled Figure E depicting a person drawing liquid from a vial into a syringe, indicating a step in preparing an injection dose.*

FDA Label Image

Figure F (Image 41)

An instructional illustration labeled as Figure F showing a hand holding a syringe and a vial, demonstrating the step of drawing insulin from the vial into the syringe, indicated by an arrow pointing downward toward the syringe.*

FDA Label Image

Figure G (Image 42)

An instructional illustration labeled Figure G showing a hand holding an injection vial upside down above a syringe with an arrow indicating the syringe plunger is being pulled down. This image likely demonstrates a step in the preparation of an injectable medication.*

FDA Label Image

Figure H (Image 43)

An instructional illustration showing a hand holding a syringe that is drawing liquid from a vial. The image demonstrates the proper technique for withdrawing medication from a vial using a syringe.*

FDA Label Image

Figure I (Image 44)

Illustration showing the proper method to withdraw a liquid medication from a vial using a syringe. The diagram emphasizes drawing the medication by pulling the syringe plunger upward, with a close-up inset showing the syringe filled partially with the liquid.*

FDA Label Image

Figure J (Image 45)

Illustration labeled as Figure J showing a hand holding a vial and drawing liquid into a syringe, demonstrating the proper technique for preparing an injection with NovoLog Mix 70/30 insulin aspart suspension.*

FDA Label Image

Figure L (Image 47)

An instructional illustration showing two hands preparing an injection using a syringe. One hand holds the syringe barrel while the other hand pulls the plunger to draw fluid, demonstrating medication preparation technique for subcutaneous injection.*

FDA Label Image

Figure M (Image 48)

Illustration depicting the proper technique for subcutaneous injection. The image shows one hand pinching the skin while the other hand inserts a syringe needle at an angle, with an arrow indicating the direction of needle insertion.*

FDA Label Image

Pull Off The Pen Cap. (Image 50)

An instructional illustration showing a close-up of hands holding and preparing an injection pen for subcutaneous use. The image demonstrates pressing or adjusting the injection mechanism, likely indicating a step in administering NovoLog Mix 70/30 injection, suspension, insulin aspart by REMEDYREPACK INC.*

FDA Label Image

Roll The Pen Between Your Palms. (Image 51)

An instructional illustration showing a hand holding an insulin injection syringe near the abdomen, demonstrating the recommended injection technique with a horizontal double-headed arrow indicating skin pinching or site movement.*

FDA Label Image

Move The Pen Up And Down. (Image 52)

An instructional diagram showing a two-step process for handling a medication device. Step 1: With the device held vertically, the user turns or adjusts the top part. Step 2: The device is then held horizontally, indicating preparation for use or administration.*

FDA Label Image

Turn The Dose Selector To 2 Units. (Image 56)

Instructional illustration showing a close-up of a hand dial turning the dose selector on an insulin pen to select a dose of 2 units. The image highlights the dose window with the number 2 visible, indicating dose adjustment for NovoLog Mix 70/30 insulin injection.*

FDA Label Image

Tap The Needle. (Image 57)

An instructional illustration showing a close-up of a syringe needle being tapped or flicked by a finger, indicating the step of removing air bubbles before injection. The image focuses on the syringe tip and finger interaction, commonly used in injection preparation guidance.*

FDA Label Image

Press The Push-button. (Image 58)

An instructional illustration showing a hand holding an injection pen device labeled with a dose indicator showing '30'. The illustration includes an upward arrow indicating to pull or remove the cap from the injection pen. An inset shows a close-up of the pen needle being attached or ready for use.*

FDA Label Image

Select Your Dose. (Image 59)

An instructional illustration showing a hand holding a NovoLog Mix 70/30 injection pen. The image highlights the pen's dosing window displaying '5 units selected' and a separate zoomed-in view showing '24 units selected', indicating how to read the dosage settings on the pen dial.*

FDA Label Image

Press The Push Button To Inject. (Image 60)

Illustration showing a hand holding a vial and turning the cap downward, indicating proper technique for preparing the NovoLog Mix 70/30 insulin aspart injection suspension for subcutaneous use.*

FDA Label Image

Keep The Needle In The Skin For At Least 6 Seconds. (Image 61)

An instructional illustration showing a subcutaneous injection technique with a syringe inserted at a shallow angle into the skin. The image emphasizes the correct placement of the needle for administering an injection beneath the skin.*

FDA Label Image

Replace The Pen Cap. (Image 62)

An instructional illustration showing a hand holding a NovoLog Mix 70/30 injection pen, pressing a button to administer the dose. The image emphasizes proper use of the injection pen for subcutaneous insulin delivery.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.